- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05271149
Dynamic Orthotic Garment in Diplegic Cerebral Palsy
March 5, 2022 updated by: Hatem Abd Elmohsen Abdel Hamid Emara, Taibah University
Effect of Dynamic Orthotic Garment on Foot Pressure Distribution, Postural Control, Functional Performance and Endurance in Spastic Diplegic Cerebral Palsy Children: Randomized Controlled Trial
This study aims to evaluate the effectiveness of dynamic orthotic garment (Thera togs) on foot pressure distribution, postural control, functional performance and endurance in children with spastic diplegic cerebral palsy (CP).
Methods: forty children with spastic diplegic CP, with ages ranging from 8 to 10 years, will be assigned randomly into two groups.
The control group will receive the conventional physical therapy, whereas the study group will receive the same program as the control group in addition to Thera togs.
Measurement of foot pressure distribution will be performed using a pressure platform, postural control will be evaluated using the trunk control measurement scale Trunk Position Sense pediatric berg balance scale, endurance will be assessed using six-minute walk test (6MWT)
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study aims to evaluate the effectiveness of dynamic orthotic garment (Thera togs) on foot pressure distribution, postural control, functional performance and endurance in children with spastic diplegic cerebral palsy (CP).
Methods: forty children with spastic diplegic CP, with ages ranging from 8 to 10 years, will be assigned randomly into two groups.
The control group will receive the conventional physical therapy, whereas the study group will receive the same program as the control group in addition to Thera togs.
Measurement of foot pressure distribution will be performed using a pressure platform, postural control will be evaluated using the trunk control measurement scale ,Trunk Position Sense , pediatric berg balance scale, endurance will be assessed using six-minute walk test (6MWT)
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hatem Emara
- Phone Number: 0564156262
- Email: dremara.2050@gmail.com
Study Contact Backup
- Name: Eman Sobh
- Phone Number: 0540418086
- Email: Emansobh2012@gmail.com
Study Locations
-
-
Almadinah Almunawarah
-
Medina, Almadinah Almunawarah, Saudi Arabia
- Recruiting
- Taibah University
-
Contact:
- AHMED Aljohani
- Phone Number: 0555313167
- Email: ahmedjj9@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 10 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- children with CP who have toe-in gait and had grade 1+ to 2 degree of spasticity according to the Modified Ashworth Scale (MAS) [32]. In addition to score I and II on Gross Motor Function Classification System (GMFCS) scores [33]. As well as the child is required to be able to stand and walk independently.
Exclusion Criteria:
- Children who have impaired hearing or vision, previous lower limb surgery or Botulinum injections of the lower limb muscles within the preceding 6 months will be excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Control group
conventional physical therapy based on neurodevelopmental techniques, This program will be given for 1 hour, 3 days a week for 12 weeks
|
Routine physical therapy and orthosis
Other Names:
|
Experimental: study group
conventional physical therapy and orthosis (Thera togs) : the child will wear the orthosis for twelve weeks, from 8 to 10 hours a day, during daily-life activities.
The child's guardian (mother) will be trained and will receive a DVD recording, with a step-by-step demonstration on the fitting of TheraTogs® in the child.
Markings were made in TheraTogs® to facilitate and improve fitting.
All necessary support will be offered, with weekly monitoring in person to control the fitting of the orthosis, as well as for possible questions or clarifications.in
addition to conventional physical therapy as the control group
|
Routine physical therapy and orthosis
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Foot pressure distribution
Time Frame: baseline
|
Static and dynamic planter pressure measurements to measure peak and mean plantar pressure for each sub-region of the foot (forefoot, mid-foot and rear-foot) expressed in kPa.
|
baseline
|
Foot pressure distribution
Time Frame: Twelve week
|
Static and dynamic planter pressure measurements to measure peak and mean plantar pressure for each sub-region of the foot (forefoot, mid-foot and rear-foot) expressed in kPa.
|
Twelve week
|
The trunk control measurement scale
Time Frame: baseline
|
to assess the static and dynamic components of trunk control.The minimum score is 1 and the maximum scor is 58.Higher score means better outcome
|
baseline
|
The trunk control measurement scale
Time Frame: Twelve week
|
to assess the static and dynamic components of trunk control .The minimum score is 1 and the maximum scor is 58.Higher score means better outcome
|
Twelve week
|
Trunk Position Sense
Time Frame: baseline
|
Active position sense of the trunk was assessed using a digital goniometer.
|
baseline
|
Trunk Position Sense
Time Frame: Twelve weeks
|
Active position sense of the trunk was assessed using a digital goniometer.
|
Twelve weeks
|
Pediatric balance scale
Time Frame: baseline
|
The Pediatric balance scale, used to determine the dynamic balancing abilities of children with cerebral palsy, shows an excellent inter-rater reliability.The minimum score is 1 and the maximum score is 56.Higher score means better outcome
|
baseline
|
Pediatric balance scale
Time Frame: Twelve weeks
|
The Pediatric balance scale, used to determine the dynamic balancing abilities of children with cerebral palsy, shows an excellent inter-rater reliability.The minimum score is 1 and the maximum score is 56.Higher score means better outcome
|
Twelve weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Six-minute walk test (6-MWT)
Time Frame: baseline
|
distance covered during six minutes will be recorded
|
baseline
|
Six-minute walk test (6-MWT)
Time Frame: Twelve weeks
|
distance covered during six minutes will be recorded
|
Twelve weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hatem Emara, PhD, Associate Professor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 17, 2022
Primary Completion (Anticipated)
May 17, 2022
Study Completion (Anticipated)
May 20, 2022
Study Registration Dates
First Submitted
February 21, 2022
First Submitted That Met QC Criteria
March 5, 2022
First Posted (Actual)
March 8, 2022
Study Record Updates
Last Update Posted (Actual)
March 8, 2022
Last Update Submitted That Met QC Criteria
March 5, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Theratog
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diplegic Cerebral Palsy
-
MTI UniversityEnrolling by invitationSpastic Diplegic Cerebral PalsyEgypt
-
Eastern Mediterranean UniversityCompletedDiplegic Cerebral Palsy With SpasticityPalestinian Territory, occupied
-
Gazi UniversityRecruitingDiplegic Cerebral Palsy With Spasticity | Pes; DeformityTurkey
-
Northwestern UniversityActive, not recruitingCerebral Palsy | Diplegic Cerebral Palsy | Bilateral Cerebral PalsyUnited States
-
Cairo UniversityCompletedDiplegic Cerebral PalsyEgypt
-
Cairo UniversityRecruitingDiplegic Cerebral PalsyEgypt
-
IRCCS Fondazione Stella MarisUniversity of Parma; IRCCS reggio emiliaNot yet recruiting
-
Mahmoud Reda ElsharkawyRecruiting
-
Riphah International UniversityRecruitingDiplegic Cerebral PalsyPakistan
-
Cairo UniversityRecruiting
Clinical Trials on Routine Physical Therapy
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompleted
-
Riphah International UniversityRecruitingCerebral PalsyPakistan
-
University of LahoreRecruitingChronic Hemorrhagic StrokePakistan
-
University of LahoreRecruitingHemiplegic Cerebral PalsyPakistan
-
University of LahoreRecruitingMild Traumatic Brain InjuryPakistan
-
Riphah International UniversityCompleted
-
University of LahoreRecruiting
-
University of LahoreRiphah International UniversityCompleted
-
University of LahoreRecruiting